Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells

Experimental Cell Research

Volumn 280, Issue 1, 2002, Pages 107-118

  Fattorossi, Andrea ^a   Battaglia, Alessandra ^a   Malinconico, Paolo ^a   Stoler, Andrea B ^a   Andreocci, Leila ^a   Parente, Dino ^b   Coscarella, Annamaria ^b   Maggiano, Nicola ^a   Perillo, Alessandro ^a   Pierelli, Luca ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

Cellular proliferation; Human T cell; Immunotherapy; Mucin; T cell activation molecules

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; MUCIN 1; PROTEIN INHIBITOR;

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; BREAST CARCINOMA; CELL ADHESION; CELL DENSITY; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PROPERTY; WESTERN BLOTTING;

EID: 18644366641     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5591     Document Type: Article

References (42)

1. Gendler, S. J., and Spicer, A. P. (1995). Epithelial mucin genes (review). Annu. Rev. Physiol. 57, 607-634.
2. Irimura, T., Denda, K., Iida, S., Takeuchi, H., and Kato, K. (1999). Diverse glycosylation of MUC1 and MUC2: Potential significance in tumor immunity. J. Biochem. 126, 975-985.
3. Williams, S. J., McGuckin, M. A., Gotley, D. C., Eyre, H. J., Sutherland, G. R., and Antalis, T. M. (1999). Two novel mucin genes downregulated in colorectal cancer identified by differential display. Cancer Res. 59, 4083-4089.
4. Bieche, I., and Lidereau, R. (1997). A gene dosage effect is responsible for the high overexpression of the MUC1 gene observed in human breast tumors. Cancer Genet. Cytogenet. 98, 75-80.
5. Williams, S. J., Wreschner, D. H., Tran, M., Eyre, H. J., Sutherland, G. R., and McGuckin, M. A. (2001). Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J. Biol. Chem. 276, 18327-18336.
6. Barrat-Boyes, S. (1996) Making the most of mucin: A novel target for immunotherapy. Cancer Immunol. Immunother. 43, 142-151.
7. Delsol, G., Gatter, K. C., Stein, H., Erber, W. N., Pulford, K. A. F., Zinne, K., and Mason, D. Y. (1984). Human lymphoid cells express epithelial membrane antigen. Lancet 2, 1124-1129.
8. Heyderman, E., and Macartney, J. C. (1985). Epithelial membrane antigen and lymphoid cells. Lancet 1, 109-110.
9. Zotter, S., Hageman, P. C., Lossnitzer, A., Mooi, W. J., and Hilgers, J. (1988). Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 11, 55-101.
10. Takahashi, T., Makiguchi, Y., Hinoda, Y., Kakiuchi, H., Nakagawa, N., Imai, K., and Yachi, A. (1994). Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from multiple myeloma patient. J. Immunol. 153, 2102-2109.
11. Chittal, S. M., and Desol, G. (1997). The interface of Hodgkin's disease and anaplastic large cell lymphoma. Cancer Surv. 30, 87-105.
12. Treon, S. P., Mollick, J. A., Urashima, M., Teoh, G., Chauhan, D., Ogata, A., Raje, N., Hilgers, J. H. M., Nadler, L., Belch, A. R., Pilarski, L. M., and Anderson, K. C. (1999). Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood 93, 1287-1298.
13. Brugger, W., Buhring, H. J., Grunebach, F., Vogel, W., Kaul, S., Muller, R., Brummendorf, T. H., Ziegler, B. L., Rappold, I., Brosart, P., Scheding, S., and Kanz, L. (1999). Expression of muc-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells. J. Clin. Oncol. 5, 1535-1544.
14. Dent, G. A., Civalier, C. J., Brecher, M. E., and Bentley, S. A. (1999). Muc1 expression in hematopoietic tissues. Am. J. Clin. Pathol. 111, 741-747.
15. Chadburn, A., Inghirami, G., and Knowles, D. M. (1992). The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD300 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematol. Pathol. 6, 193-202.
16. Agrawal, B., Krantz, M. J., Parker, J., and Longenecker, B. M. (1998). Expression of Muc1 mucin on activated human T cells: Implications for a role of muc1 in normal immune regulation. Cancer Res. 58, 4079-4081.
17. Chang, J. F., Zhao, H. L., Philips, J., and Greenburg, G. (2000). The epithelial mucin Muc1 is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation. Cell Immunol. 201, 83-88.
18. Agrawal, B., Krantz, M. J., Reddish, M. A., and Longenecker, B. M. (1998). Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 4, 43-49.
19. Kim, J. A., Dayton, M. A., Aldrich, W., and Triozzi, P. L. (1999). Modulation of CD4 cell cytokine production by colon cancer-associated mucin. Cancer Immunol. Immunother. 48, 525-532.
20. Ho, J. J. L., Cheng, S., and Kim, Y. S. (1995). Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem. Biophys. Res. Commun. 210, 866-873.
21. Battaglia, A., Fattorossi, A., Pierelli, L., Bonanno, G., Marone, M., Ranelletti, F. O., Coscarella, A., De Santis, R., Bach, S., Mancuso, S., and Scambia, G. (2000). The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis. Exp. Hematol. 28, 490-498.
22. Walsh, M. D., Luckie, S. M., Cummings, M. C., Antalis T. M., and McGuckin, M. A. (2000). Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Res. Treat. 58, 255-266.
23. Rughetti, A., Biffoni, M., Sabbatucci, M., Rahimi, H., Pellicciotta, L., Fattorossi, A., Pierelli, L., Scambia, G., Lavitrano, M., Frati, L., and Nuti, M. (2000). Transfected human dendritic cells to induce antitumor immunity. Gene Ther. 7, 1458-1466.
24. Fattorossi, A., Battaglia, A., and Ferlini, C. (2001). Lymphocyte activation associated antigens. Methods Cell Biol. 63, 433-463.
25. Blockzjil, A., Nilsson, K., and Nilsson, O. (1998). Epitope characterization of MUC1 antibodies Tumor Biol. 19 (S1), 46-56.
26. Biselli, R., Matricardi, P. M, D'Amelio, R., and Fattorossi, A. (1992). Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scand. J. Immunol. 35, 439-447.
27. Maggiano, L., Lauriola, L., Serra, F. G., Ricci, R., Capelli, A., and Ranelletti, F. O. (1999). Detection of synaptophysin-producing cells in human thymus by immunohistochemistry and nonradioactive in situ hybridization. J. Histochem. Cytochem. 47, 237-243.
28. Rowse, G. J., Tempero, R. M., VanLith, M. L., Hollingsworth, M. A., and Gendler, S. J. (1998). Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res. 58, 315-321.
29. Ferrandina, G., Stoler, A., Fagotti, A., Fanfani, F., Sacco, R., De Pasqua, A., Mancuso, S., and Scambia, G. (2000). p21WAF1/CIP1 protein expression in primary ovarian cancer. Int. J. Oncol. 17, 1231-1235.
30. Van Klinken, B. J. W., Einerhand, A. W. C., Buller, H. A., and Dekker, J. (1998). Strategic biochemical analysis of mucins. Anal. Biochem. 265, 103-116.
31. Hilkens, J., and Buijs, F. (1988). Biosynthesis of MAM-6, an epithelial sialomucin: Evidence for involvement of a rare proteolytic cleavage step in the endoplasmic reticulum. J. Biol. Chem. 263, 4215-4222.
32. Poland, P. A., Kinlough, C. L., Rokaw, M. D., Magarian-Blander, J., Finn, O. J., and Hughey, R. P. (1997). Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines. Glycoconjugate J. 14, 89-96.
33. Bedford, P., Garner, K., and Knight, S. C. (1999). MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reaction. Int. Immunol. 11, 1739-1744.
34. Nores, J. E., Bensussan, A., Vita, N., Stelter, F., Arias, M. A., Jones, M., Lefort, S., Boryslewicz, L., K., Ferrara, P., and Labeta, M. O. (1999). Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur. J. Immunol. 29, 265-276.
35. Kaufmann, M., Blaser, C., Takashima, S., Schwarts-Albiez, R., Tsuji, S., and Pircher, H. (1999). Identification of an 3-2,6-silyltransferase induced early after lymphocyte activation. Int. Immunol. 11, 731-738.
36. Sheng, Z. Q., Hull, S. R., and Carraway, K. L. (1990). Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J. Biol. Chem. 265, 8505-8510.
37. Colomer, R., Ruibal, A., Genollà, J., Rubio, D., Del Campo, J. M., Bodi, R., and Salvador, L. (1989). Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases. Breast Cancer Res. Treat. 13, 123-133.
38. Wood, W. G., Steinhoff, J., and Kessler, A. C. (1993). Anomalous tumor marker concentrations in renal transplant patients. Eur. J. Clin. Chem. Clin. Biochem. 31, 75-82.
39. Houghton, A. N., Gold, J. S., and Blachere, N. E. (2001). Immunity against cancer: Lessons learned from melanoma. Curr. Opin. Immunol. 13, 134-140.
40. Musselli, C., Ragupathy, G., Gilewski, T., Panageas K. S., Spinat, Y., and Livingston, P. O. (2002). Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1. Int. J. Cancer 97, 660-667.
41. Rettig, W. J., Garin-Chesa, P., Healey J. H., Su, S. L., Jaffe, E. A., and Old, L. J. (1992). Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci. USA 89, 10832-10836.
42. Hilkens, J., Buijs, F., and Ligtenberg, M. (1989). Complexity of MAM-6, an epithelial sialomucin associated with carcinomas. Cancer Res. 49, 786-793.